IL1B and neoplasm: However, the involvement of IL1β, particularly tumor cell IL1β crosstalk with normal resident myofibroblasts, either at a primary site (NCFs) or at a distant niche (NHFs), altering the sensitivity to cytotoxic chemotherapy has not been described.